Artificial Avidin-Based Receptors for a Panel of Small Molecules

  • Soili I. Lehtonen
  • , Antti Tullila
  • , Nitin Agrawal
  • , Sampo Kukkurainen
  • , Niklas Kähkönen
  • , Masi Koskinen
  • , Tarja K. Nevanen
  • , Mark S Johnson
  • , Tomi Airenne
  • , Markku S. Kulomaa
  • , Tiina A. Riihimäki
  • , Vesa P. Hytönen

    Research output: Contribution to journalArticleScientificpeer-review

    9 Citations (Scopus)

    Abstract

    Proteins with high specificity, affinity, and stability are needed for biomolecular recognition in a plethora of applications. Antibodies are powerful affinity tools, but they may also suffer from limitations such as low stability and high production costs. Avidin and streptavidin provide a promising scaffold for protein engineering, and due to their ultratight binding to D-biotin they are widely used in various biotechnological and biomedical applications. In this study, we demonstrate that the avidin scaffold is suitable for use as a novel receptor for several biologically active small molecules: Artificial, chicken avidin-based proteins, antidins, were generated using a directed evolution method for progesterone, hydrocortisone, testosterone, cholic acid, ketoprofen, and folic acid, all with micromolar to nanomolar affinity and significantly reduced biotin-binding affinity. We also describe the crystal structure of an antidin, sbAvd-2(I117Y), a steroid-binding avidin, which proves that the avidin scaffold can tolerate significant modifications without losing its characteristic tetrameric beta-barrel structure, helping us to further design avidin-based small molecule receptors.
    Original languageUndefined/Unknown
    Pages (from-to)211–221
    JournalACS Chemical Biology
    Volume11
    Issue number1
    DOIs
    Publication statusPublished - 2015
    MoE publication typeA1 Journal article-refereed

    Cite this